Investing in Longevity – Mitochondria Based Therapeutics
Steven Engle, CEO, CohBar, a clinical stage biotechnology company, is developing mitochondria-based therapeutics to treat chronic diseases and extend healthy lifespan which tackle the challenges of aging and prevent or…